InspireMD Inc (NSPR) Stock Analysis

InspireMD Inc (NSPR) is a publicly traded company in the HEALTHCARE sector. It trades at $1.01, carries a market capitalization of $46.37M. This page summarizes the public market data, fundamentals, and frequently asked questions for NSPR, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

• Price: $1.01
• Market Cap: $46.37M
• EPS: $-0.70
• 52-Week High: $2.93
• 52-Week Low: $0.86

Market Sentiment

InspireMD Inc currently has a Neutral sentiment score of 0.09.

About InspireMD Inc

InspireMD Inc. is a pioneering medical device company based in Tel Aviv, Israel, specializing in the development and commercialization of its proprietary MicroNet stent platform technology. This innovative solution aims to enhance patient outcomes in the treatment of coronary and vascular diseases, positioning the company for growth in key global markets including Europe, Latin America, the Middle East, and Asia. With a commitment to addressing significant needs within the cardiovascular sect...

GNG Research Analysis

GNG Research scores InspireMD Inc (NSPR) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NSPR.

Frequently Asked Questions

Does NSPR pay dividends?

InspireMD Inc (NSPR) does not currently pay a regular dividend.

What is NSPR's market cap?

InspireMD Inc (NSPR) has a market capitalization of $46.37M with a current stock price of $1.01.